Oasmia is a specialty pharmaceutical company dedicated to improving the lives of patients by enhancing the intravenous delivery of established and novel drugs in significant diseases, in several indications, including cancer.

Oasmia Pharmaceutical published its Q1 report on September 9, 2020, at 08.00 am CEST.

The Share